- Home
- APLT vs CISO Comparison
APLT vs CISO Comparison
Compare APLT & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- CISO
- Stock Information
- Founded
- APLT 2016
- CISO 2015
- Country
- APLT United States
- CISO United States
- Employees
- APLT N/A
- CISO N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- CISO Computer Software: Prepackaged Software
- Sector
- APLT Health Care
- CISO Technology
- Exchange
- APLT Nasdaq
- CISO Nasdaq
- Market Cap
- APLT 37.5M
- CISO 31.4M
- IPO Year
- APLT 2019
- CISO N/A
- Fundamental
- Price
- APLT $0.35
- CISO $1.34
- Analyst Decision
- APLT Buy
- CISO
- Analyst Count
- APLT 7
- CISO 0
- Target Price
- APLT $6.10
- CISO N/A
- AVG Volume (30 Days)
- APLT 1.4M
- CISO 2.1M
- Earning Date
- APLT 08-06-2025
- CISO 08-13-2025
- Dividend Yield
- APLT N/A
- CISO N/A
- EPS Growth
- APLT N/A
- CISO N/A
- EPS
- APLT N/A
- CISO N/A
- Revenue
- APLT $265,000.00
- CISO $29,887,603.00
- Revenue This Year
- APLT $1,768.13
- CISO N/A
- Revenue Next Year
- APLT $292.85
- CISO N/A
- P/E Ratio
- APLT N/A
- CISO N/A
- Revenue Growth
- APLT N/A
- CISO N/A
- 52 Week Low
- APLT $0.30
- CISO $0.26
- 52 Week High
- APLT $10.62
- CISO $3.84
- Technical
- Relative Strength Index (RSI)
- APLT 42.17
- CISO 60.57
- Support Level
- APLT $0.34
- CISO $0.94
- Resistance Level
- APLT $0.38
- CISO $1.07
- Average True Range (ATR)
- APLT 0.02
- CISO 0.11
- MACD
- APLT -0.00
- CISO 0.01
- Stochastic Oscillator
- APLT 7.14
- CISO 86.69
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.